Research Summary

My research focuses on the treatment of tobacco dependence and better understanding the processes of change through randomized clinical trials and related studies. I am especially interested in the treatment of comorbid and marginalized populations, and the complexities these introduce into treatment. Currently, I am collaborating with other Cancer Center Investigators on studies of the treatment of LGBTQ smokers via social media, and the treatment of homeless individuals who smoke. I have also served as a consultant to group s adapting methods from earlier clinical trials to digital media and have been actively involved in developing content for the modalities.

I have served as Director of an NIH-funded Center Grant, and a Postdoctoral Training program in drug abuse treatment research. I am a recipient of the Ove Ferno Award for Clinical Research from the Society for Research on Nicotine and Tobacco, and the George Sarlo Teaching Award.

Research Funding

  • September 30, 1991 - June 30, 2024 - Substance Use Disorders Treatment/Services Research Training Program , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: T32DA007250
  • September 29, 1994 - May 31, 2016 - Treatment for Complex Patients: Continuing and Extended Care , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: P50DA009253
  • April 1, 1980 - May 31, 2016 - Maintaining Nonsmoking , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DA002538
  • August 20, 2003 - June 30, 2013 - Treatment of Complex Patients: Emphasis on Nicotine , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K05DA016752

Education

Washington State University, B.S., 1967, Psychology
Washington State University, M.S., 1969, Psychology
Palo Alto Veterans Admin. Medical Center, Intern, 1970-1971, Psychology
Washington State University, Ph.D., 1971, Psychology

Honors & Awards

  • 1967
    Phi Kappa Phi Bachelor's Degree with Highest Honors
  • 1980
    Fellow, American Psychological Association, Divisions 28 + 38
  • 1980-1990
    ADAMHA Research Scientist Development Award
  • 1984
    Fellow, American Psychological Association, Division 28, Psychopharmacology
  • 1986
    Fellow, Society of Behavioral Medicine
  • 1987
    Fellow, Academy of Behavioral Medicine Research
  • 1989
    Fellow, Association for Clinical Psychosocial Research
  • 1990
    DVA Research Career Scientist Award
  • 2003
    George Sarlo Prize for Excellence in Teaching
  • 2003
    National Institutes of Health Senior Scientist Award

Selected Publications

  1. Miller J, Cuby J, Hall SM, Stitzer M, Kushel M, Appiah D, Vijayaraghavan M. Tobacco use behaviors and views on engaging in clinical trials for tobacco cessation among individuals who experience homelessness. Contemp Clin Trials Commun. 2023 Apr; 32:101094.  View on PubMed
  2. Molina MF, Hall SM, Stitzer M, Kushel M, Chakravarty D, Vijayaraghavan M. Contingency management to promote smoking cessation in people experiencing homelessness: Leveraging the electronic health record in a pilot, pragmatic randomized controlled trial. PLoS One. 2022; 17(12):e0278870.  View on PubMed
  3. Harrison A, Ramo D, Hall SM, Estrada-Gonzalez V, Tolou-Shams M. Cigarette Smoking, Mental Health, and Other Substance Use among Court-Involved Youth. Subst Use Misuse. 2020; 55(4):572-581.  View on PubMed
  4. Ramo DE, Thrul J, Delucchi KL, Hall S, Ling PM, Belohlavek A, Prochaska JJ. A randomized controlled evaluation of the tobacco status project, a Facebook intervention for young adults. Addiction. 2018 May 24.  View on PubMed
  5. Hall SM, Humfleet GL, Gasper JJ, Delucchi KL, Hersh DF, Guydish JR. Cigarette Smoking Cessation Intervention for Buprenorphine Treatment Patients. Nicotine Tob Res. 2018 04 02; 20(5):628-635.  View on PubMed
  6. Hall SM. Commentary on Laude et al. (2017): Extended treatment for cigarette smoking cessation. Addiction. 2017 08; 112(8):1460-1461.  View on PubMed
  7. Gubner NR, Guydish J, Humfleet GL, Benowitz NL, Hall SM. Nicotine biomarkers and rate of nicotine metabolism among cigarette smokers taking buprenorphine for opioid dependency. Drug Alcohol Depend. 2017 09 01; 178:267-270.  View on PubMed
  8. Leyro TM, Crew EE, Bryson SW, Lembke A, Bailey SR, Prochaska JJ, Henriksen L, Fortmann SP, Killen JD, Killen DT, Hall SM, David SP. Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence. BMJ Open. 2016 06 29; 6(6):e010960.  View on PubMed
  9. Hendricks PS, Hall SM, Tyus LR, Thorne CB, Lappan SN, McMurray MV, Bailey WC, Cropsey KL, Baker TB. Withdrawal exposure with withdrawal regulation training for smoking cessation: a randomized controlled pilot trial. Drug Alcohol Depend. 2016 Jul 01; 164:28-37.  View on PubMed
  10. Barnett PG, Wong W, Jeffers A, Hall SM, Prochaska JJ. Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trial. J Clin Psychiatry. 2015 Oct; 76(10):e1285-91.  View on PubMed
  11. Ramo DE, Thrul J, Delucchi KL, Ling PM, Hall SM, Prochaska JJ. The Tobacco Status Project (TSP): Study protocol for a randomized controlled trial of a Facebook smoking cessation intervention for young adults. BMC Public Health. 2015 Sep 15; 15:897.  View on PubMed
  12. Benowitz NL, Nardone N, Dains KM, Hall SM, Stewart S, Dempsey D, Jacob P. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up. Addiction. 2015 Oct; 110(10):1667-75.  View on PubMed
  13. Bergen AW, Michel M, Nishita D, Krasnow R, Javitz HS, Conneely KN, Lessov-Schlaggar CN, Hops H, Zhu AZ, Baurley JW, McClure JB, Hall SM, Baker TB, Conti DV, Benowitz NL, Lerman C, Tyndale RF, Swan GE, Transdisciplinary Research in Cancer of the Lung Research Team. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption. PLoS One. 2015; 10(7):e0126113.  View on PubMed
  14. Prochaska JJ, Fromont SC, Ramo DE, Young-Wolff KC, Delucchi K, Brown RA, Hall SM. Gender differences in a randomized controlled trial treating tobacco use among adolescents and young adults with mental health concerns. Nicotine Tob Res. 2015 Apr; 17(4):479-85.  View on PubMed
  15. Leyro TM, Hendricks PS, Hall SM. If at first you don't succeed: characterization of smokers with late smoking abstinence onset. Addict Behav. 2015 Jun; 45:34-8.  View on PubMed
  16. Hall SM, Shi Y, Humfleet GL, Mu?oz RF, Reus VI, Prochaska JJ. Smoking cessation abstinence goal in treatment-seeking smokers. Addict Behav. 2015 Mar; 42:148-53.  View on PubMed
  17. Schuck RK, Dahl A, Hall SM, Delucchi K, Fromont SC, Hall SE, Bonas T, Prochaska JJ. Smokers with serious mental illness and requests for nicotine replacement therapy post-hospitalisation. Tob Control. 2016 Jan; 25(1):27-32.  View on PubMed
  18. Bergen AW, Javitz HS, Krasnow R, Michel M, Nishita D, Conti DV, Edlund CK, Kwok PY, McClure JB, Kim RB, Hall SM, Tyndale RF, Baker TB, Benowitz NL, Swan GE. Organic cation transporter variation and response to smoking cessation therapies. Nicotine Tob Res. 2014 Dec; 16(12):1638-46.  View on PubMed
  19. Grady ES, Humfleet GL, Delucchi KL, Reus VI, Mu?oz RF, Hall SM. Smoking cessation outcomes among sexual and gender minority and nonminority smokers in extended smoking treatments. Nicotine Tob Res. 2014 Sep; 16(9):1207-15.  View on PubMed
  20. Young-Wolff KC, Fromont SC, Delucchi K, Hall SE, Hall SM, Prochaska JJ. PTSD symptomatology and readiness to quit smoking among women with serious mental illness. Addict Behav. 2014 Aug; 39(8):1231-4.  View on PubMed

Go to UCSF Profiles, powered by CTSI